US3596941068 - Common Stock

We assign a fundamental rating of **5** out of 10 to **FUL**. **FUL** was compared to 85 industry peers in the **Chemicals** industry. **FUL** has only an average score on both its financial health and profitability. **FUL** is valied quite expensively at the moment, while it does show a decent growth rate.

In the past year **FUL** was profitable.

Each year in the past 5 years **FUL** has been profitable.

The 3 year average ROIC (**5.13%**) for **FUL** is below the current ROIC(**6.04%**), indicating increased profibility in the last year.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 3.18% | ||

ROE | 8.58% | ||

ROIC | 6.04% |

ROA(3y)3.63%

ROA(5y)3.65%

ROE(3y)10.09%

ROE(5y)11.16%

ROIC(3y)5.13%

ROIC(5y)5.01%

With a **Profit Margin** value of **4.16%**, **FUL** perfoms like the industry average, outperforming **45.24%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 9.78% | ||

PM (TTM) | 4.16% | ||

GM | 27.81% |

OM growth 3Y1.17%

OM growth 5Y10.47%

PM growth 3Y2.13%

PM growth 5Y13.3%

GM growth 3Y-2.73%

GM growth 5Y-0.21%

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so **FUL** is destroying value.

Compared to 1 year ago, **FUL** has more shares outstanding

Compared to 5 years ago, **FUL** has more shares outstanding

Compared to 1 year ago, **FUL** has a worse debt to assets ratio.

The Debt to FCF ratio of **FUL** is **6.65**, which is on the high side as it means it would take **FUL**, **6.65** years of fcf income to pay off all of its debts.

Looking at the **Debt to FCF ratio**, with a value of **6.65**, **FUL** is in the better half of the industry, outperforming **64.29%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 1.09 | ||

Debt/FCF | 6.65 | ||

Altman-Z | 2.59 |

ROIC/WACC0.72

WACC8.33%

A Current Ratio of **2.01** indicates that **FUL** has no problem at all paying its short term obligations.

With a **Current ratio** value of **2.01**, **FUL** perfoms like the industry average, outperforming **48.81%** of the companies in the same industry.

A Quick Ratio of **1.24** indicates that **FUL** should not have too much problems paying its short term obligations.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 2.01 | ||

Quick Ratio | 1.24 |

The **Revenue** has been growing by **10.21%** on average over the past years. This is quite good.

EPS 1Y (TTM)-11.82%

EPS 3Y10.65%

EPS 5Y9.91%

EPS growth Q2Q0%

Revenue 1Y (TTM)-3.31%

Revenue growth 3Y8.98%

Revenue growth 5Y10.21%

Revenue growth Q2Q-4.31%

The **Revenue** is expected to grow by **1.12%** on average over the next years.

EPS Next Y-3.82%

EPS Next 2Y5.1%

EPS Next 3Y8.05%

EPS Next 5YN/A

Revenue Next Year-7.09%

Revenue Next 2Y-1.56%

Revenue Next 3Y1.12%

Revenue Next 5YN/A

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

Based on the **Price/Earnings** ratio of **22.02**, the valuation of **FUL** can be described as rather expensive.

The rest of the industry has a similar **Price/Earnings** ratio as **FUL**.

The **Price/Forward Earnings** ratio is **17.80**, which indicates a rather expensive current valuation of **FUL**.

Compared to an average S&P500 **Price/Forward Earnings** ratio of **20.05**, **FUL** is valued at the same level.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 22.02 | ||

Fwd PE | 17.8 |

Based on the **Price/Free Cash Flow** ratio, **FUL** is valued a bit cheaper than the industry average as 67.86% of the companies are valued more expensively.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 15.03 | ||

EV/EBITDA | 11.94 |

The decent profitability rating of **FUL** may justify a higher PE ratio.

PEG (NY)N/A

PEG (5Y)2.22

EPS Next 2Y5.1%

EPS Next 3Y8.05%

With a **Dividend Yield** of **1.04**, **FUL** pays less dividend than the S&P500 average, which is at **2.56**.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 1.04% |

The dividend of **FUL** has a limited annual growth rate of **4.56%**.

Dividend Growth(5Y)4.56%

Div Incr Years8

Div Non Decr Years8

The dividend of **FUL** is growing, but earnings are growing more, so the dividend growth is sustainable.

DP28.61%

EPS Next 2Y5.1%

EPS Next 3Y8.05%

**H.B. FULLER CO.**

NYSE:FUL (12/8/2023, 7:04:00 PM)

After market: 78.84 0 (0%)**78.84**

**-0.27 (-0.34%) **

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryChemicals

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap4.26B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 1.04% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 22.02 | ||

Fwd PE | 17.8 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)2.22

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 3.18% | ||

ROE | 8.58% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 9.78% | ||

PM (TTM) | 4.16% | ||

GM | 27.81% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.77

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 1.09 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 2.01 | ||

Quick Ratio | 1.24 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)-11.82%

EPS 3Y10.65%

EPS 5Y

EPS growth Q2Q

EPS Next Y-3.82%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-3.31%

Revenue growth 3Y8.98%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y